Heart failure in children: part I: history, etiology, and pathophysiology.

Why is heart failure in children important? If we just consider the number of individuals affected, adult heart failure is clearly a more compelling public health problem. However, the relatively small numbers belie the overall economic and social impact of pediatric heart failure. When a child is admitted to the hospital for heart failure, the costs are considerably higher for children than adults because of the frequent need for surgical or catheter-based intervention. The demands of medical care can fray the family structure and adversely affect parental economic productivity. When a child dies of heart failure, the economic impact is magnified enormously because of the number of potentially productive years lost per death. For these and other reasons, heart failure in children is a serious public health concern. In addition, growing numbers of children with heart failure are reaching adulthood because of the successful application of medical and surgical heart failure therapies and the improved outcomes of congenital heart surgery. A greater understanding of the pathophysiology of heart failure in childhood may help inform therapeutic strategies once these children become adults. Furthermore, given the recent explosion of research in the impact of cardiac development and cardiogenetics on pediatric cardiovascular disease, it is not outside the realm of possibility for a pediatric discovery to be made that will also benefit adults with heart failure. We may not yet be able to agree on a definition of heart failure, but the cardinal symptoms, dyspnea, anasarca (“dropsy”), and cachexia, were well recognized in antiquity.1 These symptoms were not specific for cardiac pathology, and it was not until the 17th century, when William Harvey definitively identified the heart as an organ that pumped blood rather than generating heat, that the heart could begin to be understood as a source of dyspnea, edema, and …

[1]  Alan,et al.  Diseases of Children , 1885, The Indian medical gazette.

[2]  B. F. Massell,et al.  The clinical picture of rheumatic fever: diagnosis, immediate prognosis, course, and therapeutic implications. , 1958, The American journal of cardiology.

[3]  E. Goldblatt.  The treatment of cardiac failure in infancy. A review of 350 cases. , 1962, Lancet.

[4]  G R HERRMANN,et al.  Congestive heart failure. , 1962, Geriatrics.

[5]  A. J. Hauck,et al.  HEART FAILURE IN INFANTS AND CHILDREN. SURVEY OF RECENT LITERATURE, ETIOLOGIC CONSIDERATIONS AND RECOMMENDATIONS FOR THERAPY. , 1963, Postgraduate medicine.

[6]  M. Kreidberg,et al.  Treatment of cardiac failure in infancy and childhood. , 1963, The New England journal of medicine.

[7]  M. A. Engle.  When the child's heart fails: Recognition, treatment, prognosis. , 1970, Progress in cardiovascular diseases.

[8]  W. Silverman.  Human Experimentation: A Guided Step into the Unknown , 1985 .

[9]  L. Mahony,et al.  Developmental changes in cardiac sarcoplasmic reticulum in sheep. , 1986, The Journal of biological chemistry.

[10]  M. Artman,et al.  Inotropic responses change during postnatal maturation in rabbit. , 1988, The American journal of physiology.

[11]  R. Sade.  Transposition of the Great Arteries , 1988 .

[12]  H. Gray,et al.  Characterisation of the normal right ventricular pressure-volume relation by biplane angiography and simultaneous micromanometer pressure measurements. , 1988, British heart journal.

[13]  H. Matsuda,et al.  Assessment of ventricular contractile state and function in patients with univentricular heart. , 1989, Circulation.

[14]  C. Morris,et al.  25-year mortality after surgical repair of congenital heart defect in childhood. A population-based cohort study. , 1991, JAMA.

[15]  A. Mills,et al.  Greater permeability of the neonatal lung. Postnatal changes in surface charge and biochemistry of porcine pulmonary capillary endothelium. , 1991, The Journal of thoracic and cardiovascular surgery.

[16]  M. Dolgin,et al.  Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels , 1994 .

[17]  R. W. Joyner,et al.  Developmental Changes in Modulation of Contractility of Rabbit Hearts , 1995, Journal of cardiovascular pharmacology.

[18]  E. Clark,et al.  The Developing Heart: A ‘History’ of Pediatric Cardiology , 1995, Developments in Cardiovascular Medicine.

[19]  Bohuslav Ošt̕ádal,et al.  The developing heart , 1997 .

[20]  A. Katz,et al.  Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle--Part I. , 1997, Journal of cardiac failure.

[21]  D. Mancini,et al.  Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. , 1999, Circulation.

[22]  A. Rudolph,et al.  Myocardial growth before and after birth: clinical implications * , 2000, Acta paediatrica.

[23]  B. Pisani.  Heart Failure: Pathophysiology, Molecular Biology and Clinical Management , 2000 .

[24]  A. Wessel,et al.  Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease , 2001, Critical care medicine.

[25]  R. Ross,et al.  Medical Management of Chronic Heart Failure in Children , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[26]  J Wray,et al.  Congenital heart disease and cardiac surgery in childhood: effects on cognitive function and academic ability , 2001, Heart.

[27]  B. Griffith,et al.  Cardiopulmonary transplantation for congenital heart disease in the adult. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  M. Henein,et al.  Abnormalities of right ventricular long axis function after atrial repair of transposition of the great arteries , 2001, Heart.

[29]  A. Rudolph,et al.  Congenital Diseases of the Heart: Clinical-Physiological Considerations , 2001 .

[30]  A. Wessel,et al.  Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. , 2001, International journal of cardiology.

[31]  H. Gardiner.  Heart failure at the extremes of life: Chalk and cheese? , 2001 .

[32]  M. Artman,et al.  The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. , 2001, The Journal of pediatrics.

[33]  Y. Cheung,et al.  Outcome of infants with right atrial isomerism: is prognosis better with normal pulmonary venous drainage? , 2002, Heart.

[34]  M. Timio,et al.  Ippolito Albertini and Michael Albertus: Disparate Old and Innovative Theories on Dropsy and Edema , 2002, American Journal of Nephrology.

[35]  P. Lundberg,et al.  Increased levels of brain and atrial natriuretic peptides after the first palliative operation, but not after a bidirectional Glenn anastomosis, in children with functionally univentricular hearts , 2003, Cardiology in the Young.

[36]  P. Chondros,et al.  The epidemiology of childhood cardiomyopathy in Australia , 2003 .

[37]  M. Konstam.  "Systolic and diastolic dysfunction" in heart failure? Time for a new paradigm. , 2003, Journal of cardiac failure.

[38]  T. Yagihara,et al.  Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart Disease , 2003, Circulation.

[39]  J. Towbin,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States , 2003 .

[40]  W. Pinsky,et al.  Grading the severity of congestive heart failure in infants , 1992, Pediatric Cardiology.

[41]  Yiming Wu,et al.  Developmental Control of Titin Isoform Expression and Passive Stiffness in Fetal and Neonatal Myocardium , 2004, Circulation research.

[42]  P. Lundberg,et al.  Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy , 2004, Acta paediatrica.

[43]  J. Bartunek,et al.  Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[44]  J. Towbin,et al.  International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  Douglas L Mann,et al.  Mechanisms and models in heart failure: the biomechanical model and beyond. , 2005, Circulation.

[46]  A. Schmaltz,et al.  Herzinsuffizienz im Kindesalter , 1999, Herz Kardiovaskuläre Erkrankungen.

[47]  A. Schmaltz,et al.  [Congestive heart failure in childhood. An epidemiologic study]. , 2005, Herz.

[48]  A. Nir,et al.  Clinical value of NT-ProBNP and BNP in pediatric cardiology. , 2005, Journal of cardiac failure.

[49]  G. Wernovsky,et al.  Pediatric Heart Failure , 2005 .

[50]  N. Mensi,et al.  Comparison of classifications for heart failure in children undergoing valvular surgery. , 2006, The Journal of pediatrics.

[51]  H. Singer,et al.  B-type natriuretic peptide in paediatric patients with congenital heart disease. , 2006, European heart journal.

[52]  C. Warnes.  Transposition of the great arteries. , 2006, Circulation.

[53]  V. Rousson,et al.  Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. , 2006, The Annals of thoracic surgery.

[54]  J. H. Patterson,et al.  Executive Summary Executive Summary : HFSA 2010 Comprehensive Heart Failure Practice Guideline , 2022 .

[55]  S. Colan,et al.  Incidence, causes, and outcomes of dilated cardiomyopathy in children. , 2006, JAMA.

[56]  D. Rosenthal,et al.  Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study , 2006, BMC cardiovascular disorders.

[57]  V. Tsang,et al.  Transplantation for adults with congenital heart disease. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[58]  K. Norozi,et al.  Is the Ability index superior to the NYHA classification for assessing heart failure? , 2007, Clinical Research in Cardiology.

[59]  Paul Aurora,et al.  Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[60]  L. D’Orsogna.  Heart Failure in Children and Young Adults , 2007 .

[61]  O. Trojnarska.  Heart failure in the adult patient with congenital heart disease. , 2007, Cardiology journal.

[62]  M. Desai,et al.  Genomic profiling of left and right ventricular hypertrophy in congenital heart disease. , 2008, Journal of cardiac failure.

[63]  H. Baumgartner.  Neurohormones in valvular heart disease: what can they tell us? , 2008, European heart journal.

[64]  Tal Geva,et al.  Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. , 2008, Journal of the American College of Cardiology.

[65]  John K. Triedman,et al.  Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery , 2008, Circulation.

[66]  A. Rahmel,et al.  Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric heart transplantation report--2008. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[67]  W. Koch,et al.  Gene therapy in heart failure. , 2008, Circulation research.

[68]  Michael Burch,et al.  New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland , 2008, Circulation.

[69]  M. Massin,et al.  Epidemiology of Heart Failure in a Tertiary Pediatric Center , 2008, Clinical cardiology.

[70]  B. Bruneau,et al.  Tbx5-dependent pathway regulating diastolic function in congenital heart disease , 2008, Proceedings of the National Academy of Sciences.

[71]  E. Braunwald.  The management of heart failure: the past, the present, and the future. , 2008, Circulation. Heart failure.

[72]  T. Meyer,et al.  Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy. , 2008, The Journal of thoracic and cardiovascular surgery.

[73]  Mario Stylianou,et al.  Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age. , 2008, The Journal of thoracic and cardiovascular surgery.

[74]  J. Stockman.  Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry , 2009 .

[75]  S. Ball,et al.  Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. , 2009, Cardiovascular research.

[76]  J. Stockman.  Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial , 2009 .

[77]  Jack Rychik,et al.  Heart Failure in the Fetus with Congenital Heart Disease , 2010 .

[78]  M. Silberbach,et al.  Heart failure in infants and children. , 2010, Pediatrics in review.